A detailed history of Daiwa Securities Group Inc. transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 195 shares of PRTA stock, worth $3,139. This represents 0.0% of its overall portfolio holdings.

Number of Shares
195
Previous 195 -0.0%
Holding current value
$3,139
Previous $4,000 25.0%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 06, 2023

BUY
$52.05 - $65.0 $2,134 - $2,665
41 Added 26.62%
195 $12,000
Q3 2021

Nov 05, 2021

BUY
$48.2 - $78.89 $3,181 - $5,206
66 Added 75.0%
154 $11,000
Q4 2020

Feb 04, 2021

BUY
$10.12 - $13.94 $890 - $1,226
88 New
88 $1,000
Q3 2020

Nov 02, 2020

SELL
$9.93 - $13.47 $2,105 - $2,855
-212 Closed
0 $0
Q1 2019

Apr 26, 2019

BUY
$10.32 - $14.49 $2,187 - $3,071
212 New
212 $3,000
Q4 2018

Feb 05, 2019

SELL
$8.73 - $13.74 $1,850 - $2,912
-212 Closed
0 $0
Q1 2018

May 02, 2018

BUY
$27.95 - $45.04 $5,925 - $9,548
212 New
212 $8,000

Others Institutions Holding PRTA

About PROTHENA CORP PUBLIC LTD CO


  • Ticker PRTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,922,800
  • Market Cap $755M
  • Description
  • Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...
More about PRTA
Track This Portfolio

Track Daiwa Securities Group Inc. Portfolio

Follow Daiwa Securities Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Daiwa Securities Group Inc. with notifications on news.